Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03275948

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

The purpose of the study is to investigate, in healthy middle age subjects, effects of whole grain rye on cognitive functions, mood, and cardiovasculair risk markers

Lead sponsor: Lund University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment38

Start dateNov 2016

Last updatedOct 4, 2017

Condition

Metabolic Disorders and Cognitive Decline

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 4, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions